AEON Biopharma
AEON
AEON
24 hedge funds and large institutions have $8.73M invested in AEON Biopharma in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
92% less capital invested
Capital invested by funds: $103M → $8.73M (-$94.7M)
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$94.6K | |
| 2 | +$50.7K | |
| 3 | +$47.7K | |
| 4 |
BlackRock
New York
|
+$17.7K |
| 5 |
KL
KIM LLC
Wichita,
Kansas
|
+$16.3K |
Top Sellers
| 1 | -$331K | |
| 2 | -$248K | |
| 3 | -$167K | |
| 4 |
Goldman Sachs
New York
|
-$166K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$60.3K |